Hedge Fund - OrbiMed Advisors

Sinovac Biotech Ltd (SVA) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $333,996,595 7.96% 2,718,735 $6.47
2 2024 - Q4 (2024-12-31) $333,996,595 6.87% 2,718,735 $6.47
3 2024 - Q3 (2024-09-30) $340,000,000 6.17% 2,718,735 $6.47
4 2024 - Q2 (2024-06-30) $340,000,000 6.71% 2,718,735 $6.47
5 2024 - Q1 (2024-03-31) $340,000,000 6.22% 2,718,735 $6.47
6 2023 - Q4 (2023-12-31) $340,000,000 6.79% 2,718,735 $6.47
7 2023 - Q3 (2023-09-30) $340,000,000 7.22% 2,718,735 $6.47
8 2023 - Q2 (2023-06-30) $340,000,000 6.16% 2,718,735 $6.47
9 2023 - Q1 (2023-03-31) $340,000,000 6.67% 2,718,735 $6.47
10 2022 - Q4 (2022-12-31) $340,000,000 6.5% 2,718,735 $6.47
11 2022 - Q3 (2022-09-30) $340,500,000 6.32% 2,718,735 $6.47
12 2022 - Q2 (2022-06-30) $349,500,000 6.33% 2,718,735 $6.47
13 2022 - Q1 (2022-03-31) $0 0% 0 $6.47
14 2021 - Q4 (2021-12-31) $72,700,000 0.93% 2,839,500 $6.47
15 2021 - Q3 (2021-09-30) $78,400,000 0.86% 2,839,500 $6.47
16 2021 - Q2 (2021-06-30) $76,800,000 0.77% 2,839,500 $6.47
17 2021 - Q1 (2021-03-31) $72,000,000 0.67% 2,839,500 $6.47
18 2020 - Q4 (2020-12-31) $72,000,000 0.63% 2,839,500 $6.47
19 2020 - Q3 (2020-09-30) $27,300,000 0.34% 2,839,500 $6.47
20 2020 - Q2 (2020-06-30) $25,500,000 0.35% 2,839,500 $6.47
21 2020 - Q1 (2020-03-31) $17,151,000 0.28% 2,839,500 $6.47
22 2019 - Q4 (2019-12-31) $17,151,000 0.24% 2,839,500 $6.47
23 2019 - Q3 (2019-09-30) $16,611,000 0.31% 2,839,500 $6.47
24 2019 - Q2 (2019-06-30) $16,611,000 0.25% 2,839,500 $6.47
25 2019 - Q1 (2019-03-31) $18,372,000 0.28% 2,839,500 $6.53
26 2018 - Q4 (2018-12-31) $19,706,000 0.36% 2,839,500 $7.30
27 2018 - Q3 (2018-09-30) $21,637,000 0.26% 2,839,500 $7.22
28 2018 - Q2 (2018-06-30) $21,183,000 0.25% 2,839,500 $7.87
29 2018 - Q1 (2018-03-31) $24,448,000 0.3% 2,839,500 $8.24
30 2017 - Q4 (2017-12-31) $22,375,000 0.28% 2,839,500 $7.48
31 2017 - Q3 (2017-09-30) $18,806,000 0.17% 2,667,500 $6.83
32 2017 - Q2 (2017-06-30) $18,006,000 0.18% 2,667,500 $5.48
33 2017 - Q1 (2017-03-31) $15,285,000 0.17% 2,667,500 $5.79
34 2016 - Q4 (2016-12-31) $15,738,000 0.2% 2,667,500 $6.01
35 2016 - Q3 (2016-09-30) $15,738,000 0.17% 2,667,500 $5.88
36 2016 - Q2 (2016-06-30) $15,818,000 0.16% 2,667,500 $6.13
37 2016 - Q1 (2016-03-31) $17,045,000 0.17% 2,667,500 $6.00
38 2015 - Q4 (2015-12-31) $15,258,000 0.13% 2,667,500 $5.38
39 2015 - Q3 (2015-09-30) $13,551,000 0.13% 2,667,500 $5.30
40 2015 - Q2 (2015-06-30) $14,004,000 0.11% 2,667,500 $5.28
41 2015 - Q1 (2015-03-31) $13,231,000 0.11% 2,667,500 $4.93
42 2014 - Q4 (2014-12-31) $14,756,000 0.14% 2,821,500 $5.10
43 2014 - Q3 (2014-09-30) $13,571,000 0.14% 2,821,500 $5.37
44 2014 - Q2 (2014-06-30) $9,236,000 0.1% 1,637,500 $6.07
45 2014 - Q1 (2014-03-31) $11,790,000 0.14% 1,637,500 $6.62
46 2013 - Q4 (2013-12-31) $10,022,000 0.14% 1,637,500 $6.03
47 2013 - Q3 (2013-09-30) $11,268,000 0.2% 1,884,200 $4.78
48 2013 - Q2 (2013-06-30) $7,405,000 0.15% 1,884,200 $3.72
49 2013 - Q1 (2013-03-31) $7,766,000 0.18% 2,087,700 $3.39
50 2012 - Q4 (2012-12-31) $716,000 0.02% 228,000 $2.84
51 2012 - Q3 (2012-09-30) $0 0% 0 $2.25
52 2012 - Q1 (2012-03-31) $508,000 0.01% 249,000 $2.15
53 2011 - Q4 (2011-12-31) $548,000 0.01% 249,000 $2.22

The displayed share prices are average quarterly stock market prices.